Xylem affirms FY2026 adjusted EPS and sales guidance range
Xylem affirms FY2026 adjusted EPS guidance of $5.55–$5.70 versus a $5.54 analyst estimate, and affirms FY2026 sales guidance of $9.200B versus a $9.254B estimate.
Xylem (NYSE: XYL ) affirms FY2026 Adj EPS guidance from $5.55-$5.70 to $5.55-$5.70 vs $5.54 analyst estimate.
Affirms FY2026 sales outlook from $9.200 billion to $9.200 billion vs $9.254 billion estimate.